Whole-Body Diffusion-weighted MR Imaging in Cancer: Current Status and Research Directions
Top Cited Papers
- 1 December 2011
- journal article
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 261 (3), 700-718
- https://doi.org/10.1148/radiol.11110474
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Is Apparent Diffusion Coefficient Associated with Clinical Risk Scores for Prostate Cancers that Are Visible on 3-T MR Images?Radiology, 2011
- ADC histograms predict response to anti-angiogenic therapy in patients with recurrent high-grade gliomaNeuroradiology, 2010
- Whole-body diffusion-weighted imaging for staging malignant lymphoma in childrenPediatric Radiology, 2010
- Is Computed Tomography Safe?The New England Journal of Medicine, 2010
- Predicting and monitoring cancer treatment response with diffusion‐weighted MRIJournal of Magnetic Resonance Imaging, 2010
- Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularityJournal of Magnetic Resonance Imaging, 2010
- The value of diffusion-weighted imaging for monitoring the chemotherapeutic response of osteosarcoma: a comparison between average apparent diffusion coefficient and minimum apparent diffusion coefficientSkeletal Radiology, 2009
- The parametric response map is an imaging biomarker for early cancer treatment outcomeNature Medicine, 2009
- Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic womenOsteoporosis International, 2008
- Integration of quantitative DCE-MRI and ADC mapping to monitor treatment response in human breast cancer: initial resultsMagnetic Resonance Imaging, 2007